Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens.

Srivastava, Nityanand; Usmani, Salman Sadullah; Subbarayan, Rajasekaran; Saini, Rashmi; Pandey, Pranav Kumar

Srivastava, Nityanand; Usmani, Salman Sadullah; Subbarayan, Rajasekaran; Saini, Rashmi; Pandey, Pranav Kumar.

Afiliación

Srivastava N; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, United States.
Usmani SS; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, United States.
Subbarayan R; Department of Radiation Oncology, Albert Einstein College of Medicine, Bronx, NY, United States.
Saini R; Research, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Educations, Chennai, India.
Pandey PK; Department of Zoology, Gargi College, University of Delhi, New Delhi, India.

Front Oncol ; 13: 1199105, 2023.

Article en En | MEDLINE | ID: mdl-37492478

Palabras clave

DNA damage response; HIF-1; Hypoxia; TNBC; cancer vaccines; chemotherapy; immune escape; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google